Unknown

Dataset Information

0

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.


ABSTRACT: A role for B-cell-receptor (BCR) signalling in lymphomagenesis has been inferred by studying immunoglobulin genes in human lymphomas and by engineering mouse models, but genetic and functional evidence for its oncogenic role in human lymphomas is needed. Here we describe a form of 'chronic active' BCR signalling that is required for cell survival in the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL). The signalling adaptor CARD11 is required for constitutive NF-kappaB pathway activity and survival in ABC DLBCL. Roughly 10% of ABC DLBCLs have mutant CARD11 isoforms that activate NF-kappaB, but the mechanism that engages wild-type CARD11 in other ABC DLBCLs was unknown. An RNA interference genetic screen revealed that a BCR signalling component, Bruton's tyrosine kinase, is essential for the survival of ABC DLBCLs with wild-type CARD11. In addition, knockdown of proximal BCR subunits (IgM, Ig-kappa, CD79A and CD79B) killed ABC DLBCLs with wild-type CARD11 but not other lymphomas. The BCRs in these ABC DLBCLs formed prominent clusters in the plasma membrane with low diffusion, similarly to BCRs in antigen-stimulated normal B cells. Somatic mutations affecting the immunoreceptor tyrosine-based activation motif (ITAM) signalling modules of CD79B and CD79A were detected frequently in ABC DLBCL biopsy samples but rarely in other DLBCLs and never in Burkitt's lymphoma or mucosa-associated lymphoid tissue lymphoma. In 18% of ABC DLBCLs, one functionally critical residue of CD79B, the first ITAM tyrosine, was mutated. These mutations increased surface BCR expression and attenuated Lyn kinase, a feedback inhibitor of BCR signalling. These findings establish chronic active BCR signalling as a new pathogenetic mechanism in ABC DLBCL, suggesting several therapeutic strategies.

SUBMITTER: Davis RE 

PROVIDER: S-EPMC2845535 | biostudies-literature | 2010 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.

Davis R Eric RE   Ngo Vu N VN   Lenz Georg G   Tolar Pavel P   Young Ryan M RM   Romesser Paul B PB   Kohlhammer Holger H   Lamy Laurence L   Zhao Hong H   Yang Yandan Y   Xu Weihong W   Shaffer Arthur L AL   Wright George G   Xiao Wenming W   Powell John J   Jiang Jian-Kang JK   Thomas Craig J CJ   Rosenwald Andreas A   Ott German G   Muller-Hermelink Hans Konrad HK   Gascoyne Randy D RD   Connors Joseph M JM   Johnson Nathalie A NA   Rimsza Lisa M LM   Campo Elias E   Jaffe Elaine S ES   Wilson Wyndham H WH   Delabie Jan J   Smeland Erlend B EB   Fisher Richard I RI   Braziel Rita M RM   Tubbs Raymond R RR   Cook J R JR   Weisenburger Dennis D DD   Chan Wing C WC   Pierce Susan K SK   Staudt Louis M LM  

Nature 20100101 7277


A role for B-cell-receptor (BCR) signalling in lymphomagenesis has been inferred by studying immunoglobulin genes in human lymphomas and by engineering mouse models, but genetic and functional evidence for its oncogenic role in human lymphomas is needed. Here we describe a form of 'chronic active' BCR signalling that is required for cell survival in the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL). The signalling adaptor CARD11 is required for constitutive NF-kapp  ...[more]

Similar Datasets

2010-01-11 | GSE18817 | GEO
| S-EPMC5151177 | biostudies-literature
| S-EPMC5813722 | biostudies-literature
| S-EPMC8377611 | biostudies-literature
| S-EPMC8372245 | biostudies-literature
| S-EPMC6887546 | biostudies-literature
| S-EPMC8408091 | biostudies-literature
| S-EPMC3508519 | biostudies-literature
| S-EPMC6144206 | biostudies-literature
2002-06-27 | E-GEOD-60 | biostudies-arrayexpress